Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ColoREDIT
2024-520262-58-01Phase 4Authorised
- Sponsor
- Region Västmanland
- Start
- Jan 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of morphine, bupivacaine, fentanyl and epinephrine in colorectal cancer (CRC) and Colorectal disease (2 arms), sponsored by Region Västmanland. Planned start Jan 2026; status: authorised.
02
Drugs
morphinebupivacainefentanylepinephrine
03
Conditions
colorectal cancer (CRC)Colorectal disease
Beyond the preview
Go deeper on 2024-520262-58-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520262-58-01.